Search

Boehringer Ingelheim opens Health Management Centre in China

Boehringer Ingelheim opens Health Management Centre in China The new Health Management Centre integrates animal disease and health diagnostics as well as monitoring tools The centre further strengthens the company’s ability to provide services along the f

Phase II results cognitive impairment schizophrenia

Presented at ECNP Congress, Phase II trial results demonstrated improvement in cognition with BI 425809 in schizophrenia patients

Phase 1 start of treatment for Geographic Atrophy patients

Boehringer initiates Phase 1 evaluation of BI 771716 a treatment for preserving vision of people living with geographic atrophy (GA)

Lameness horses collaboration Sleip app artificial intelligence

The Sleip app uses artificial intelligence (AI) to provide objective analysis of a horse’s movement with just a smartphone.

The little things

In 2009 Anna was diagnosed with scleroderma. For her, however, the disease is no reason to give up. On the contrary.

Horses

Animal Health partnering interests

Partnering pet therapeutics

Learn more about our research focus and our most recent partnerships regarding pet therapeutics.

New partnership to develop schizophrenia treatments

Boehringer Ingelheim partners with Sosei Heptares to develop next generation schizophrenia treatments

ArisGlobal acquires Boehringer Ingelheim technology

Boehringer Ingelheim’s signal analytics technology is acquired by ArisGlobal

Partnership canine oncology

The collaboration will focus on identifying new molecules to target cancers in dogs. Small molecules could provide superior disease control.

Inauguration of new global center for veterinary vaccine R&D

Inauguration of a new global hi-tech centre for biological research and development in Lyon.

Groundbeaking of vaccine production center in France

Boehringer Ingelheim breaks ground on its strategic vaccine production center for veterinary public health

Boehringer Ingelheim supports collaboration and knowledge sharing in the livestock industry

Boehringer Ingelheim demonstrates its commitment to farm animal well-being by organising its 11th Expert Forum on Farm Animal Well-Being

Award winning employer

Boehringer Ingelheim focuses on the wellbeing of its employees – and is therefore also a "Global Top Employer 2023".

Science Stories

Boehringer Ingelheim leader in hatchery vaccination

Boehringer Ingelheim is a leader in hatchery vaccination with vector vaccines.

Boehringer and ZEISS partnership eye diseases

Boehringer Ingelheim and ZEISS join forces to early detect eye diseases and prevent vision loss

additional-investment-in-Lyon-Jonage

Boehringer Ingelheim to expand veterinary vaccine capacity for emerging and transboundary diseases in France

On two wheels for more animal health

Cowtribe’s social entrepreneurs win Boehringer Ingelheim's Accelerator Program.

Survodutide US FDA Breakthrough Therapy phase 3 trials MASH

Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide

Option to Acquire Trutino Biosciences

Veterinary oncology experts meet in Germany

Veterinary oncology experts meet prior to the European Society of Veterinary Oncology Congress in Hofheim, Germany

A career at the intersection of science and marketing

A member of the Animal Health digital marketing team, our colleague Missy talks about her purpose to bring transformative technologies to the vet community

NeO - smart and sustainable vaccines

The reduction in the environmental impact of the new NeO vaccine packaging illustrates Boehringer Ingelheim’s drive for environmental responsibility.

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers